Effect of erlotinib plus bevacizumab vs erlotinib alone on progression-free survival in patients with advanced EGFR-mutant non–small cell lung cancer: a phase 2 …
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA …, 2019 - jamanetwork.com
Importance Erlotinib is a standard first-line therapy for patients with epidermal growth factor
receptor (EGFR)–mutant non–small cell lung cancer (NSCLC). Median progression-free …
receptor (EGFR)–mutant non–small cell lung cancer (NSCLC). Median progression-free …
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 …
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA …, 2019 - europepmc.org
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients
With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical …
With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical …
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 …
TE Stinchcombe, PA Jänne, X Wang… - JAMA …, 2019 - pubmed.ncbi.nlm.nih.gov
Importance Erlotinib is a standard first-line therapy for patients with epidermal growth factor
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
[引用][C] Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A …
TE Stinchcombe, PA Jänne, C Lau, C Paweletz… - JAMA oncology, 2019 - elibrary.ru
[HTML][HTML] Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer: A …
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA …, 2019 - ncbi.nlm.nih.gov
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in
Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer - PMC Back to Top Skip to …
Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer - PMC Back to Top Skip to …
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 …
TE Stinchcombe, PA Jänne, X Wang… - JAMA …, 2019 - ohiostate.elsevierpure.com
Importance: Erlotinib is a standard first-line therapy for patients with epidermal growth factor
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 …
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA …, 2019 - profiles.wustl.edu
Importance: Erlotinib is a standard first-line therapy for patients with epidermal growth factor
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free …
[引用][C] Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA Oncology, 2019 - cir.nii.ac.jp
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients
With Advanced <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer | CiNii Research CiNii 国立 …
With Advanced <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer | CiNii Research CiNii 国立 …
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 …
TE Stinchcombe, PA Jänne, X Wang, EM Bertino… - JAMA …, 2019 - europepmc.org
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients
With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical …
With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical …